Weather is again taking a toll on the U.S. supply of injected drugs. Pfizer is idling its Hospira sterile injectables plant in Rocky Mount, North Carolina, ahead of Hurricane Florence. More: Pfizer suspending operations at U.S. injectables plant as hurricane
read moreLiva Pharmaceuticals, a wholly owned manufacturing facility of Indian drugmaker Cadila Healthcare, was hit with a Form 483 by the FDA following an inspection of its plant in Vadodara, India. More: Cadila manufacturing facility in India gets FDA Form 483
read moreHere is some other vaccine news of note for the week. More: News of Note—IMV combo trial, Sanofi, ImmusanT and more Source: fierce
read morePfizer and Merck KGaA are one step closer to a brand-new market for their immuno-oncology drug Bavencio. The companies reported winning data in a kidney cancer trial, setting them up for a “breakthrough” FDA approval—and a key expansion for the
read moreBristol-Myers Squibb’s bid to win U.K. coverage for Opdivo as a melanoma postsurgery recurrence prevention therapy has hit a snag, as NICE has rejected its application due to lack of overall survival data. More: NICE nixes Opdivo as postsurgery melanoma
read moreThe Scottish Medicines Consortium has cleared funds for use of four new medicines by NHS Scotland, including Sanofi’s biologic Dupixent for dermatitis. More: Four new medicines available via NHS Scotland Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals